Alex Mauron
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alex Mauron has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- A. Bottani
Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland
1 shared publication - A. Vannier
Service of Genetic Medicine, University Hospitals of Geneva, Geneva, Switzerland
1 shared publication - Ariane Paoloni-Giacobino
Service de médecine génétique, HUG, 1211 Genève 14
1 shared publication - C. Moret
Institute for Ethics, History, and the Humanities, Geneva University Medical School, Geneva, Switzerland
1 shared publication - Celine Brockmann
Bioscope, University of Geneva
1 shared publication Celine Moret
A Geneva University Medical School
1 shared publication
Latest Publications
- Open Access
- 28 June 2016
- Published by Springer Nature in Human Genomics
- Vol. 10 (1) , 24
Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders
In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary “Genome Clinic Task Force” at the University Hospitals of Geneva, which is composed of clinical and molecular geneticists, bioinformaticians, technicians, bioethicists, and a coordinator. We have implemented whole exome sequencing (WES) with subsequent targeted bioinformatics analysis of gene lists for specific disorders. Clinical cases of heterogeneous Mendelian disorders that could potentially benefit from HTS are presented and discussed during the sessions of the task force. Debate concerning the interpretation of identified variants and the content of the final report constitutes a major part of the task force’s work. Furthermore, issues related to bioethics, genetic counseling, quality control, and reimbursement are also addressed. This multidisciplinary task force has enabled us to create a platform for regular exchanges between all involved experts in order to deal with the multiple complex issues related to HTS in clinical practice and to continuously improve the diagnostic use of HTS. In addition, this task force was instrumental to formally approve the reimbursement of HTS for molecular diagnosis of Mendelian disorders in Switzerland.
- 28 June 2016
- Published by Springer Nature in Human Genomics
- Vol. 10 (1) , 24
Open AccessExperience of a multidisciplinary task force with exome sequencing for Mendelian disorders
In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary “Genome Clinic Task Force” at the University Hospitals of Geneva, which is composed of clinical and molecular geneticists, bioinformaticians, technicians, bioethicists, and a coordinator. We have implemented whole exome sequencing (WES) with subsequent targeted bioinformatics analysis of gene lists for specific disorders. Clinical cases of heterogeneous Mendelian disorders that could potentially benefit from HTS are presented and discussed during the sessions of the task force. Debate concerning the interpretation of identified variants and the content of the final report constitutes a major part of the task force’s work. Furthermore, issues related to bioethics, genetic counseling, quality control, and reimbursement are also addressed. This multidisciplinary task force has enabled us to create a platform for regular exchanges between all involved experts in order to deal with the multiple complex issues related to HTS in clinical practice and to continuously improve the diagnostic use of HTS. In addition, this task force was instrumental to formally approve the reimbursement of HTS for molecular diagnosis of Mendelian disorders in Switzerland.
- Open Access
- 27 July 2015
- Published by MathDoc/Centre Mersenne in Comptes Rendus. Biologies
- Vol. 338 (8-9) , 566-570
Choosing among possible persons: The ethics of prenatal selection in the postgenomic age
The “spectre of eugenics” is often raised about various current reproductive practices that imply a form of choice between future possible persons. Some of these practices are linked to genetic technologies such as pre-implantation genetic diagnosis, others merely entail the choice of a procreator having specific traits, such as in artificial insemination with donor. The weight and limits of this reproof of eugenics are examined, with special attention to the conceptual problems resulting from confusing choices involving virtual persons with the selection of existing persons.
- 27 July 2015
- Published by MathDoc/Centre Mersenne in Comptes Rendus. Biologies
- Vol. 338 (8-9) , 566-570
Open AccessChoosing among possible persons: The ethics of prenatal selection in the postgenomic age
The “spectre of eugenics” is often raised about various current reproductive practices that imply a form of choice between future possible persons. Some of these practices are linked to genetic technologies such as pre-implantation genetic diagnosis, others merely entail the choice of a procreator having specific traits, such as in artificial insemination with donor. The weight and limits of this reproof of eugenics are examined, with special attention to the conceptual problems resulting from confusing choices involving virtual persons with the selection of existing persons.
- 3 July 2015
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 15 (7) , 26-28
Variants of Unknown Significance and Their Impact on Autonomy
(2015). Variants of Unknown Significance and Their Impact on Autonomy. The American Journal of Bioethics: Vol. 15, No. 7, pp. 26-28.
- 3 July 2015
- Published by Taylor & Francis in The American Journal of Bioethics
- Vol. 15 (7) , 26-28
Variants of Unknown Significance and Their Impact on Autonomy
(2015). Variants of Unknown Significance and Their Impact on Autonomy. The American Journal of Bioethics: Vol. 15, No. 7, pp. 26-28.
- 16 October 2013
- Vol. 9 (402) , 1922-3
[Read Tolstoy or revise the patho?].
- 5 June 2013
- Vol. 9 (389) , 1234
[Caffe lungo].
- 6 March 2013
- Vol. 9 (376) , 530-1
[Epigenetics].
- 21 November 2012
- Vol. 8 (363) , 2242-3
[Talk about something else].
- 19 September 2012
- Vol. 8 (354) , 1795
[Autism, stem cells, and magical powder].
- 16 May 2012
- Vol. 8 (341) , 1074-5
[The taste for risk, taken by others, of course].
- 2 March 2012
- Vol. 195, 1023-31
[Ethical aspects of preimplantation genetic diagnosis (PGD)].
The controversy surrounding PGD has not abated in recent times. This is especially the case for PGD-based tissue typing, which is used to select a future child who could serve as a stem cell donor for an older sick sibling. We examine three types of ethical argument cited against PGD in general, and specifically against tissue-typing PGD. These arguments focus on the moral status of the early embryo, the eugenics issue, and the charge that the future child is being exploited. We conclude that none of these three arguments is unassailable, and that it is the reproductive freedom of couples considering PGD that should prevail.
- 2 March 2012
- Vol. 195, 1023-31
[Ethical aspects of preimplantation genetic diagnosis (PGD)].
The controversy surrounding PGD has not abated in recent times. This is especially the case for PGD-based tissue typing, which is used to select a future child who could serve as a stem cell donor for an older sick sibling. We examine three types of ethical argument cited against PGD in general, and specifically against tissue-typing PGD. These arguments focus on the moral status of the early embryo, the eugenics issue, and the charge that the future child is being exploited. We conclude that none of these three arguments is unassailable, and that it is the reproductive freedom of couples considering PGD that should prevail.